Axon Misses Q3 Estimates as Federal Drone Delays Hit Sales, Shares Fall

Direct answer

Axon, the public safety technology company behind TASER and police body cameras, reported record third quarter revenue of $909 million, up 28 percent from a year earlier, but the result still missed what analysts expected. The company also cut its full year revenue outlook, because three large federal counter-drone orders slipped out of 2026. Shares fell about 10 percent in after-hours trading on Thursday, November 5, 2026.

What happened

Axon released its third quarter 2026 results on November 5, 2026. Revenue was $908.6 million, up 28 percent year over year, but below the consensus estimate of about $936 million. Adjusted earnings per share were $1.72, below the consensus of about $1.89.

The miss came from timing, not from weak demand across the business. Three federal Dedrone deployments, worth about $130 million in total, were delayed and are no longer expected in 2026. Dedrone is Axon’s counter-drone business, which detects and stops unauthorised drones. Because of the delay, Axon cut its full year 2026 revenue guidance to $3.61 billion to $3.63 billion, or about 30 percent growth, down from a prior range of 32 to 34 percent growth. Guidance for the fourth quarter, $990 million to $1.01 billion, also came in below what analysts expected.

Other parts of the business stayed strong. Software and Services revenue rose 43 percent to $437 million, and annual recurring revenue climbed 40 percent to $1.75 billion. Axon swung to a net profit of $57 million, or $0.68 per share, from a net loss of $2.2 million a year earlier.

Axon also announced a $1.2 billion investment in drone maker Skydio, lifting its ownership stake to 37 percent and making Axon the exclusive distributor of Skydio products for public safety in the United States and Canada. The transactions are expected to close in the fourth quarter of 2026 and the first quarter of 2027.

Why it matters for beginners

This result shows a lesson that trips up many new investors: a company can grow fast and still disappoint the market. Revenue rose 28 percent and hit a record, yet the shares fell, because investors were judging Axon against higher expectations, not against last year alone.

It also shows how one delayed order can move a whole quarter. The $130 million of delayed federal work is small next to a full year of more than $3.6 billion in revenue, but it was enough to cut the outlook and change how investors felt about the year.

The Skydio investment is the other half of the story. Axon is betting that drones will become a bigger part of police work, and it is spending $1.2 billion to own a larger share of that future. A big bet like that can pay off over years, but it also adds risk in the short term. For a beginner, the useful question is not whether one quarter was good or bad, but whether the long term plan still makes sense. Our guide to what risk in investing means explains how to think about that trade off.

What to watch next

Watch whether the three delayed federal Dedrone deployments come back in 2027, as that would restore some of the revenue Axon removed from this year. Watch the Skydio deal as it closes in the coming months, and whether Skydio reaches about $1 billion in bookings this fiscal year. Watch fourth quarter revenue against the $990 million to $1.01 billion range Axon guided, and watch whether software growth stays near 40 percent, since that recurring revenue is the steadiest part of the business.

Frequently asked questions

What does Axon do?

Axon makes public safety technology. Its best known products are TASER conducted energy weapons and body cameras used by police, plus software for managing evidence and, through Dedrone, systems that detect and stop unauthorised drones.

Why did the shares fall if revenue grew 28 percent?

Because the market expected more. Revenue of $909 million missed the consensus of about $936 million, earnings of $1.72 per share missed the $1.89 consensus, and the full year outlook was cut. Investors price shares on expectations, so a miss against those expectations can push the price down even when sales grow.

What is Dedrone, and why did it matter this quarter?

Dedrone is Axon’s counter-drone business. Three large federal Dedrone deployments were delayed, removing about $130 million of revenue expected in 2026. That delay was the main reason Axon cut its full year guidance.

What is the Skydio investment?

Axon is investing an additional $1.2 billion in Skydio, a drone maker, raising its stake to 37 percent. Axon also becomes the exclusive distributor of Skydio products for public safety in the United States and Canada. Skydio expects about $1 billion in bookings this fiscal year.

Sources

MarketBeat reported Axon’s third quarter 2026 results on November 5, 2026: https://www.marketbeat.com/instant-alerts/earnings-axon-enterprise-nasdaq-axon-issues-quarterly-earnings-results-2026-11-05/

Axon’s third quarter 2026 results, distributed by PR Newswire on November 5, 2026 and summarised by TradingView: https://www.tradingview.com/news/tradingview:ce2fd396a79c6:0-axon-enterprise-inc-axon-q3-revenue-rose-28-to-909m-2026-growth-outlook-is-about-30/

This article is for general information and education only. It is not legal or financial advice.